Virulence Profiles of Wild-Type, P.1 and Delta SARS-CoV-2 Variants in K18-hACE2 Transgenic Mice

被引:8
|
作者
Santos, Yasmin da Silva [1 ,2 ]
Gamon, Thais Helena Martins [3 ]
de Azevedo, Marcela Santiago Pacheco [3 ,4 ]
Telezynski, Bruna Larotonda [3 ]
de Souza, Edmarcia Elisa [5 ]
de Oliveira, Danielle Bruna Leal [3 ,6 ]
Dombrowski, Jamille Gregorio [4 ]
Rosa-Fernandes, Livia [3 ,7 ]
Palmisano, Giuseppe [7 ,8 ]
Carvalho, Leonardo Jose de Moura [2 ]
Luvizotto, Maria Cecilia Rui [9 ]
Wrenger, Carsten [5 ]
Covas, Dimas Tadeu [10 ,11 ]
Curi, Rui [12 ,13 ]
Marinho, Claudio Romero Farias [4 ]
Durigon, Edison Luiz [3 ,14 ]
Epiphanio, Sabrina [1 ]
机构
[1] Univ Sao Paulo, Fac Pharmaceut Sci, Dept Clin & Toxicol Anal, Lab Cellular & Mol Immunopathol Malaria, BR-05508000 Sao Paulo, SP, Brazil
[2] Fundacao Oswaldo Cruz, Oswaldo Cruz Inst, Lab Malaria Res, BR-21040900 Rio De Janeiro, Brazil
[3] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Lab Clin & Mol Virol, BR-05508000 Sao Paulo, Brazil
[4] Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Lab Expt Immunoparasitol, BR-05508000 Sao Paulo, SP, Brazil
[5] Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Unit Drug Discovery, BR-05508000 Sao Paulo, Brazil
[6] Hosp Israelita Albert Einstein, BR-05652900 Sao Paulo, Brazil
[7] Univ Sao Paulo, Dept Parasitol, GlycoProte Lab, ICB, BR-05508000 Sao Paulo, Brazil
[8] Macquarie Univ, Sch Nat Sci, Sydney 2109, Australia
[9] Sao Paulo State Univ, Sch Vet Med Aracatuba, BR-16050680 Sao Paulo, Brazil
[10] Butantan Inst, BR-05508040 Sao Paulo, Brazil
[11] Univ Sao Paulo, Ribeirao Preto Med Sch, BR-14049900 Ribeirao Preto, Brazil
[12] Cruzeiro Univ, Interdisciplinary Program Hlth Sci, BR-08060070 Sao Paulo, Brazil
[13] Butantan Inst, Bioind Ctr, Immunobiol Prod Sect, BR-05503900 Sao Paulo, Brazil
[14] Univ Sao Paulo, Sci Plataform Pasteur, BR-05508020 Sao Paulo, Brazil
来源
VIRUSES-BASEL | 2023年 / 15卷 / 04期
基金
巴西圣保罗研究基金会;
关键词
SARS-CoV-2; COVID-19; Gamma variant; Delta variant; variants of concern; K18-hACE2; INFECTION; COVID-19; OMICRON; BRAZIL;
D O I
10.3390/v15040999
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Since December 2019, the world has been experiencing the COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and we now face the emergence of several variants. We aimed to assess the differences between the wild-type (Wt) (Wuhan) strain and the P.1 (Gamma) and Delta variants using infected K18-hACE2 mice. The clinical manifestations, behavior, virus load, pulmonary capacity, and histopathological alterations were analyzed. The P.1-infected mice showed weight loss and more severe clinical manifestations of COVID-19 than the Wt and Delta-infected mice. The respiratory capacity was reduced in the P.1-infected mice compared to the other groups. Pulmonary histological findings demonstrated that a more aggressive disease was generated by the P.1 and Delta variants compared to the Wt strain of the virus. The quantification of the SARS-CoV-2 viral copies varied greatly among the infected mice although it was higher in P.1-infected mice on the day of death. Our data revealed that K18-hACE2 mice infected with the P.1 variant develop a more severe infectious disease than those infected with the other variants, despite the significant heterogeneity among the mice.
引用
收藏
页数:16
相关论文
共 50 条
  • [41] Protection of K18-hACE2 Mice against SARS-CoV-2 Challenge by a Capsid Virus-like Particle-Based Vaccine
    Myeni, Sebenzile K.
    Leijs, Anouk A.
    Bredenbeek, Peter J.
    Morales, Shessy Torres
    Linger, Marissa E.
    Fougeroux, Cyrielle
    van Zanen-Gerhardt, Sophie
    Zander, Serge A. L.
    Sander, Adam F.
    Kikkert, Marjolein
    VACCINES, 2024, 12 (07)
  • [42] SARS-CoV-2 variants of concern elicit divergent early immune responses in hACE2 transgenic mice
    Fricke, Charlie
    Pfaff, Florian
    Ulrich, Lorenz
    Halwe, Nico Joel
    Schoen, Jacob
    Timm, Laura
    Hoffmann, Weda
    Rauch, Susanne
    Petsch, Benjamin
    Hoffmann, Donata
    Beer, Martin
    Corleis, Bjoern
    Dorhoi, Anca
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2023, 53 (12)
  • [43] Incubation Periods of SARS-CoV-2 Wild-Type, Delta, and Omicron Variants-Dominant Periods in Singapore
    Conceicao, Edwin Philip
    Xu, Yingqi
    Chan, Sze Ling
    Yee, Shoon Jin
    Yue, Yang
    Arora, Shalvi
    Ong, Marcus Eng Hock
    Sim, Jean Xiang Ying
    Venkatachalam, Indumathi
    COVID, 2024, 4 (10): : 1578 - 1584
  • [44] Functional heterogeneity of mesenchymal stem cells and their therapeutic potential in the K18-hACE2 mouse model of SARS-CoV-2 infection
    da Silva, Katia Nunes
    Marim, Fernanda Martins
    Rocha, Gisele Vieira
    Costa-Ferro, Zaquer Suzana Munhoz
    Franca, Luciana Souza de Aragao
    Nonaka, Carolina Kymie Vasques
    Paredes, Bruno Diaz
    Rossi, Erik Aranha
    Loiola, Erick Correia
    Adanho, Corynne Stephanie Ahouefa
    Cunha, Rachel Santana
    da Silva, Mayck Medeiros Amaral
    Cruz, Fernanda Ferreira
    Costa, Vivian Vasconcelos
    Zanette, Dalila Luciola
    Rocha, Clarissa Araujo Gurgel
    Aguiar, Renato Santana
    Rocco, Patricia Rieken Macedo
    Souza, Bruno Solano de Freitas
    STEM CELL RESEARCH & THERAPY, 2025, 16 (01)
  • [45] NRICM101 ameliorates SARS-CoV-2-S1-induced pulmonary injury in K18-hACE2 mice model
    Wei, Wen-Chi
    Tsai, Keng-Chang
    Liaw, Chia-Ching
    Chiou, Chun-Tang
    Tseng, Yu-Hwei
    Liao, Geng-You
    Lin, Yu-Chi
    Chiou, Wen-Fei
    Liou, Kuo-Tong
    Yu, I-Shing
    Shen, Yuh-Chiang
    Su, Yi-Chang
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [46] DNA immunization with in silico predicted T-cell epitopes protects against lethal SARS-CoV-2 infection in K18-hACE2 mice
    Persson, Gry
    Restori, Katherine H.
    Emdrup, Julie Hincheli
    Schussek, Sophie
    Klausen, Michael Schantz
    Nicol, McKayla J.
    Katkere, Bhuvana
    Rono, Birgitte
    Kirimanjeswara, Girish
    Sorensen, Anders Bundgaard
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [47] Combined mutations in nonstructural protein 14, envelope, and membrane proteins mitigate the neuropathogenicity of SARS-CoV-2 Omicron BA.1 in K18-hACE2 mice
    Sangare, Kotou
    Liu, Shufeng
    Selvaraj, Prabhuanand
    Stauft, Charles B.
    Starost, Matthew F.
    Wang, Tony T.
    MSPHERE, 2025, 10 (01)
  • [48] Improved survival of SARS COV-2-infected K18-hACE2 mice treated with adenosine A2AR agonist
    Mann, Barbara J.
    Chhabra, Preeti
    Ma, Mingyang
    Brovero, Savannah G.
    Hannan, Riley T.
    Sturek, Jeffrey M.
    Jones, Marieke K.
    Linden, Joel
    Brayman, Kenneth L.
    HELIYON, 2023, 9 (08)
  • [49] Biodistribution and Cellular Internalization of Inactivated SARS-CoV-2 in Wild-Type Mice
    Hudak, Anett
    Morgan, Gareth
    Bacovsky, Jaromir
    Patai, Roland
    Polgar, Tamas F.
    Letoha, Annamaria
    Pettko-Szandtner, Aladar
    Vizler, Csaba
    Szilak, Laszlo
    Letoha, Tamas
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (14)
  • [50] Differential responses of lung and intestinal microbiota to SARS-CoV-2 infection: a comparative study of the Wuhan and Omicron strains in K18-hACE2 Tg mice
    Chae Won Kim
    Keun Bon Ku
    Insu Hwang
    Hi Eun Jung
    Kyun-Do Kim
    Heung Kyu Lee
    Laboratory Animal Research, 41 (1)